使用手动动力学测量对肥胖儿科患者肌肉强度的研究
Álvaro Martín Rivada1, Mercedes Murray Hurtado1, Elena Sánchez Camacho2
1Servicio de Pediatría, Sección Nutrición y Errores Innatos del Metabolismo, Complejo Hospitalario Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.
Anales de pediatria
|February 11, 2026
概括
与同龄人相比,肥胖儿童表现出正常的肌肉力量. 无脂肪质量是握力强度的关键预测指标,强调体力活动和瘦肉质量的重要性.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 运动医学 运动医学
- 营养科学 营养科学
背景情况:
- 儿童肥胖是一个日益关注的问题,它可能会对身体发育产生影响.
- 肌肉力量是儿童整体健康和功能能力的关键组成部分.
- 了解影响儿童肥胖症肌肉强度的因素对于有针对性的干预至关重要.
研究的目的:
- 根据参考值,评估肥胖儿童和青少年的握力.
- 分析肌肉力量,身体组成和临床/生化标志物之间的关系.
- 为了确定这个人群中肌肉力量的预测因素.
主要方法:
- 125名患有肥胖症的儿科患者 (6-16岁) 的回顾性观察队列研究.
- 收集的数据包括身体活动,人体测量,生物阻抗分析和动力测量.
- 与参考值进行比较,并进行相关性分析.
主要成果:
- 肥胖儿童的平均肌肉强度Z-score为+0.71,不低于参考值.
- 无脂肪质量是肌肉力量的最强的积极预测因素.
- 在4.8%的患者中观察到肌力衰竭 (肌肉强度低),特别是在青春期前的儿童中.
结论:
- 肥胖儿童的肌肉力量与健康的同龄人相当.
- 无脂肪质量是肌肉力量的主要决定因素.
- 身体活动和瘦身量对儿童肥胖症的力量有积极的影响.
关键词:
身体组成 身体组成身体的构成 身体的构成动力计量手册 动力计量手册电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电阻电肌肉的力量 肌肉的力量电气阻力电气阻力手动动力测仪手动动力测仪肌肉力量 肌肉力量是指肌肉的力量.儿童肥胖问题 儿童肥胖问题儿童肥胖症 儿童肥胖症相关概念视频
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Muscles of the Forearm that Move the Hand and Fingers
2.7K
The muscles of the forearm that move the wrist, hand, and digits are numerous and diverse. They can be classified into two groups based on their location and function — the anterior and posterior compartment muscles.
Anterior Compartment
The anterior compartment muscles originate from the humerus. They primarily function as flexors and are also known as flexor muscles. They typically insert on the carpals, metacarpals, and phalanges. The superficial layer includes the flexor carpi...
Anterior Compartment
The anterior compartment muscles originate from the humerus. They primarily function as flexors and are also known as flexor muscles. They typically insert on the carpals, metacarpals, and phalanges. The superficial layer includes the flexor carpi...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion
277
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism
246
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
296
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
296


